Search Results
Search for other papers by Xianghui Meng in
Google Scholar
PubMed
Search for other papers by Shuhang Xu in
Google Scholar
PubMed
Search for other papers by Guofang Chen in
Google Scholar
PubMed
Search for other papers by Michael Derwahl in
Google Scholar
PubMed
Search for other papers by Chao Liu in
Google Scholar
PubMed
only for type 2 diabetics with or without proliferative thyroid disease but also for those with metabolic syndrome and obesity. However, more associated studies are necessary to analyze the effects of metformin in these patients. Declaration of
Biochemistry and Pediatrics, School of Medicine and Biomedical Sciences, Women and Children's Hospital of Buffalo, Departments of
Search for other papers by Anshu Gupta in
Google Scholar
PubMed
Search for other papers by Malathi Srinivasan in
Google Scholar
PubMed
Search for other papers by Supaporn Thamadilok in
Google Scholar
PubMed
Search for other papers by Mulchand S Patel in
Google Scholar
PubMed
Introduction Recent studies published by the NHANES III survey point to an alarming increase in the prevalence of obesity, metabolic syndrome and type 2 diabetes in adults as well as in children ( Flegal et al . 2002 ). In 1999–2000, within the US
Search for other papers by Odelia Katz in
Google Scholar
PubMed
Search for other papers by Matthew Stuible in
Google Scholar
PubMed
Search for other papers by Nathalia Golishevski in
Google Scholar
PubMed
Search for other papers by Lilach Lifshitz in
Google Scholar
PubMed
Search for other papers by Michel L Tremblay in
Google Scholar
PubMed
Search for other papers by Max Gassmann in
Google Scholar
PubMed
Search for other papers by Moshe Mittelman in
Google Scholar
PubMed
Search for other papers by Drorit Neumann in
Google Scholar
PubMed
in clinical practice and is especially relevant in subjects with metabolic syndrome. Metabolic syndrome is common, affecting more than 30% of adults in the United States ( Feldeisen & Tucker 2007 ), and is referred to as a ‘cluster of metabolic
Division of Metabolic and Vascular Health, Warwickshire Institute for the Study of Diabetes, Clinical Sciences Research Laboratories, Warwick Medical School, University Hospital Site, University of Warwick, Coventry CV2 2DX, UK
Search for other papers by M K Piya in
Google Scholar
PubMed
Search for other papers by P G McTernan in
Google Scholar
PubMed
Division of Metabolic and Vascular Health, Warwickshire Institute for the Study of Diabetes, Clinical Sciences Research Laboratories, Warwick Medical School, University Hospital Site, University of Warwick, Coventry CV2 2DX, UK
Search for other papers by S Kumar in
Google Scholar
PubMed
↑ In human obesity, metabolic syndrome, T2DM and CVD McTernan et al . (2002 a , 2006) and Schwartz & Lazar (2011) PAI-1 Potent inhibitor of fibrinolytic pathway Expressed by Sc and Om AT. Positive correlation with abdominal adiposity ↑ In human
Faculty of Medicine, National Yang-Ming University, Taipei, Taiwan
Search for other papers by Jinn-Yang Chen in
Google Scholar
PubMed
Division of Nephrology, Wen-Lin Hemodialysis Unit, Taipei, Taiwan
Search for other papers by Deng-Yuan Jian in
Google Scholar
PubMed
Search for other papers by Chih-Chan Lien in
Google Scholar
PubMed
Search for other papers by Yu-Ting Lin in
Google Scholar
PubMed
Search for other papers by Ching-Heng Ting in
Google Scholar
PubMed
Search for other papers by Luen-Kui Chen in
Google Scholar
PubMed
Search for other papers by Ting-Chia Hsu in
Google Scholar
PubMed
Search for other papers by Hsuan-Min Huang in
Google Scholar
PubMed
Search for other papers by Yu-Ting Wu in
Google Scholar
PubMed
Search for other papers by Tse-Ting Kuan in
Google Scholar
PubMed
Section of Nephrology, Department of Internal Medicine, Heping Branch, Taipei City Hospital, Taipei, Taiwan
Search for other papers by Yu-Wen Chao in
Google Scholar
PubMed
Search for other papers by Liang-Yi Wu in
Google Scholar
PubMed
Search for other papers by Seng-Wong Huang in
Google Scholar
PubMed
Department of Medical Research and Education, Taipei Veterans General Hospital, Taipei, Taiwan
Department of Education and Research, Taipei City Hospital, Taipei, Taiwan
Search for other papers by Chi-Chang Juan in
Google Scholar
PubMed
Introduction Overweight and obesity now constitute a global public health crisis. They associate with metabolic syndrome, abdominal obesity, glucose intolerance, insulin resistance, lipid profile abnormalities and elevated blood pressure
Center of Excellence in Cardiac Electrophysiology Research, Chiang Mai University, Chiang Mai, Thailand
Cardiac Electrophysiology Unit, Department of Physiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand
Search for other papers by Nattayaporn Apaijai in
Google Scholar
PubMed
Center of Excellence in Cardiac Electrophysiology Research, Chiang Mai University, Chiang Mai, Thailand
Cardiac Electrophysiology Unit, Department of Physiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand
Search for other papers by Kewarin Jinawong in
Google Scholar
PubMed
Center of Excellence in Cardiac Electrophysiology Research, Chiang Mai University, Chiang Mai, Thailand
Cardiac Electrophysiology Unit, Department of Physiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand
Search for other papers by Kodchanan Singhanat in
Google Scholar
PubMed
Center of Excellence in Cardiac Electrophysiology Research, Chiang Mai University, Chiang Mai, Thailand
Search for other papers by Thidarat Jaiwongkam in
Google Scholar
PubMed
Center of Excellence in Cardiac Electrophysiology Research, Chiang Mai University, Chiang Mai, Thailand
Search for other papers by Sasiwan Kerdphoo in
Google Scholar
PubMed
Center of Excellence in Cardiac Electrophysiology Research, Chiang Mai University, Chiang Mai, Thailand
Department of Oral Biology and Diagnostic Sciences, Faculty of Dentistry, Chiang Mai University, Chiang Mai, Thailand
Search for other papers by Siriporn C Chattipakorn in
Google Scholar
PubMed
Center of Excellence in Cardiac Electrophysiology Research, Chiang Mai University, Chiang Mai, Thailand
Cardiac Electrophysiology Unit, Department of Physiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand
Search for other papers by Nipon Chattipakorn in
Google Scholar
PubMed
Introduction Long-term high-fat diet (HFD) consumption is known to cause metabolic syndrome, which is the cluster of obesity, insulin resistance, dyslipidemia, and hypertension ( Lai et al. 2014 ). Metabolic syndrome increases the
Search for other papers by Zachary Silver in
Google Scholar
PubMed
Search for other papers by Sam Abbott-Tate in
Google Scholar
PubMed
Search for other papers by Lindsay Hyland in
Google Scholar
PubMed
Search for other papers by Frances Sherratt in
Google Scholar
PubMed
Search for other papers by Barbara Woodside in
Google Scholar
PubMed
Search for other papers by Alfonso Abizaid in
Google Scholar
PubMed
glucocorticoid exposure in Cushing’s disease is associated with symptoms of metabolic syndrome such as weight gain, increased adiposity, hypertension and insulin resistance ( Rebuffé-Scrive et al. 1992 , Boscaro et al. 2001 , Bertagna et al. 2009
Search for other papers by Kaiyuan Yang in
Google Scholar
PubMed
Search for other papers by Jonathan Gotzmann in
Google Scholar
PubMed
Search for other papers by Sharee Kuny in
Google Scholar
PubMed
Search for other papers by Hui Huang in
Google Scholar
PubMed
Department of Ophthalmology and Visual Sciences, University of Alberta, Edmonton, Alberta, Canada
Search for other papers by Yves Sauvé in
Google Scholar
PubMed
Department of Physiology, University of Alberta, Edmonton, Alberta, Canada
Search for other papers by Catherine B Chan in
Google Scholar
PubMed
diet), they develop a metabolic syndrome-like phenotype characterized by hyperinsulinemia preceding hyperglycemia (insulin resistance), as well as other landmark features of metabolic syndrome, including abdominal adiposity and weight gain, increased
Search for other papers by Henri Wallaschofski in
Google Scholar
PubMed
, showing a promising perspective for personalized medicine in endocrinology. Declaration of interest H W is involved in the subprojects ‘Personalized Metabolomics’, ‘Biobanking’, and ‘Comorbidities in Metabolic Syndrome’ of the project ‘Greifswald Approach
Search for other papers by Bee K Tan in
Google Scholar
PubMed
Search for other papers by Jing Chen in
Google Scholar
PubMed
Search for other papers by Raghu Adya in
Google Scholar
PubMed
Search for other papers by Manjunath Ramanjaneya in
Google Scholar
PubMed
Search for other papers by Vanlata Patel in
Google Scholar
PubMed
Search for other papers by Harpal S Randeva in
Google Scholar
PubMed
, hyperandrogenism, and associated with features of the metabolic syndrome, particularly, obesity and diabetes ( Dunaif 1997 , Diamanti-Kandarakis 2006 , Diamanti-Kandarakis et al . 2006 ). The metabolic syndrome is associated with excessive accumulation of